194 related articles for article (PubMed ID: 15940613)
21. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
[TBL] [Abstract][Full Text] [Related]
22. Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial.
Sung MW; Yeh HC; Thung SN; Schwartz ME; Mandeli JP; Chen SH; Woo SL
Mol Ther; 2001 Sep; 4(3):182-91. PubMed ID: 11545608
[TBL] [Abstract][Full Text] [Related]
23. [Approaches to gene therapy of hepatocellular carcinoma].
Ameis D
Internist (Berl); 2000 Feb; 41(2 Pt 2):208-12. PubMed ID: 10756437
[No Abstract] [Full Text] [Related]
24. Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium.
Wu JC; Chen IY; Wang Y; Tseng JR; Chhabra A; Salek M; Min JJ; Fishbein MC; Crystal R; Gambhir SS
Circulation; 2004 Aug; 110(6):685-91. PubMed ID: 15302807
[TBL] [Abstract][Full Text] [Related]
25. Persistent postnatal transgene expression in both muscle and liver after fetal injection of recombinant adenovirus.
Yang EY; Kim HB; Shaaban AF; Milner R; Adzick NS; Flake AW
J Pediatr Surg; 1999 May; 34(5):766-72; discussion 772-3. PubMed ID: 10359179
[TBL] [Abstract][Full Text] [Related]
26. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
[TBL] [Abstract][Full Text] [Related]
27. Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector.
O'Neal WK; Zhou H; Morral N; Langston C; Parks RJ; Graham FL; Kochanek S; Beaudet AL
Mol Med; 2000 Mar; 6(3):179-95. PubMed ID: 10965494
[TBL] [Abstract][Full Text] [Related]
28. Combined radionuclide-chemotherapy and in vivo imaging of hepatocellular carcinoma cells after transfection of a triple-gene construct, NIS, HSV1-sr39tk, and EGFP.
Lee YL; Lee YJ; Ahn SJ; Choi TH; Moon BS; Cheon GJ; Lee SW; Ahn BC; Ha JH; Lee J
Cancer Lett; 2010 Apr; 290(1):129-38. PubMed ID: 19819065
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated gene transfer into tumors: evaluation of direct readministration of an adenoviral vector into subcutaneous tumors of immunocompetent mice.
Nagao S; Kuriyama S; Okuda H; Tominaga K; Nakatani T; Tsujinoue H; Yoshiji H; Fukui H
Int J Oncol; 2001 Jan; 18(1):57-65. PubMed ID: 11115539
[TBL] [Abstract][Full Text] [Related]
30. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
[TBL] [Abstract][Full Text] [Related]
31. Further reduction in adenovirus vector-mediated liver transduction without largely affecting transgene expression in target organ by exploiting microrna-mediated regulation and the Cre-loxP recombination system.
Bennett D; Sakurai F; Shimizu K; Matsui H; Tomita K; Suzuki T; Katayama K; Kawabata K; Mizuguchi H
Mol Pharm; 2012 Dec; 9(12):3452-63. PubMed ID: 23127182
[TBL] [Abstract][Full Text] [Related]
32. Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases.
Gnant MF; Noll LA; Irvine KR; Puhlmann M; Terrill RE; Alexander HR; Bartlett DL
J Natl Cancer Inst; 1999 Oct; 91(20):1744-50. PubMed ID: 10528025
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
Okada Y; Okada N; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T
Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
[TBL] [Abstract][Full Text] [Related]
34. Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.
Grünwald GK; Vetter A; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Wagner E; Göke B; Holm PS; Ogris M; Spitzweg C
J Nucl Med; 2013 Aug; 54(8):1450-7. PubMed ID: 23843567
[TBL] [Abstract][Full Text] [Related]
35. Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma.
Goebel EA; Davidson BL; Graham SM; Kern JA
Otolaryngol Head Neck Surg; 1998 Oct; 119(4):331-6. PubMed ID: 9781985
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
37. Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer.
Palmer DH; Mautner V; Mirza D; Oliff S; Gerritsen W; van der Sijp JR; Hubscher S; Reynolds G; Bonney S; Rajaratnam R; Hull D; Horne M; Ellis J; Mountain A; Hill S; Harris PA; Searle PF; Young LS; James ND; Kerr DJ
J Clin Oncol; 2004 May; 22(9):1546-52. PubMed ID: 15051757
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
[TBL] [Abstract][Full Text] [Related]
39. Double-Dose Adenovirus-Mediated Adjuvant Gene Therapy Improves Liver Transplantation Outcomes in Patients with Advanced Hepatocellular Carcinoma.
Zhu R; Weng D; Lu S; Lin D; Wang M; Chen D; Lv J; Li H; Lv F; Xi L; Zhou J; Ma D; Li N
Hum Gene Ther; 2018 Feb; 29(2):251-258. PubMed ID: 29446997
[TBL] [Abstract][Full Text] [Related]
40. Immune regulation of transgene expression in the brain: B cells regulate an early phase of elimination of transgene expression from adenoviral vectors.
Zirger JM; Liu C; Barcia C; Castro MG; Lowenstein PR
Viral Immunol; 2006; 19(3):508-17. PubMed ID: 16987068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
